Realcan Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 62.7% in First Three Quarters of 2022

Realcan Pharmaceutical Group Co.,Ltd. (瑞康医药集团股份有限公司) (002589.SZ) reported a net profit of 145.4 million yuan in the first three quarters of 2022, down 62.7% year-on-year.

Meanwhile, the company posted 10.9 billion yuan in revenue, down 38.2% year-on-year.

At the end of the reporting period, it had 23.8 billion yuan in total assets and 15.2 billion yuan in total liabilities, with a liability-to-asset ratio of 64%.